Childhood and adolescent depression

American Family Physician

Volumn 75, Issue 1, 2007, Pages

  Bhatia, Shashi K ^a   Bhatia, Subhash C ^a,b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; HYPERICUM PERFORATUM EXTRACT; ISOTRETINOIN; LITHIUM; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGITATION; AKATHISIA; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DROWSINESS; EVIDENCE BASED MEDICINE; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HOSTILITY; HUMAN; MENTAL CONCENTRATION; NAUSEA; PATIENT MONITORING; REVIEW; RISK FACTOR; SCREENING; SIDE EFFECT; SOCIAL PSYCHOLOGY; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW; TREATMENT DURATION; TREMOR; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; COGNITIVE THERAPY; DEPRESSIVE DISORDER; HUMANS; RISK FACTORS; SUICIDE;

EID: 33846092063     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Shaffer D, Gould MS, Fisher P, Trautman P, Moreau D, Kleinman M, et al. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 1996;53:339-48.
2. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 1996;35:1427-39.
3. Garrison CZ, Waller JL, Cuffe SP, McKeown RE, Addy CL, Jackson KL. Incidence of major depressive disorder and dysthymia in young adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:458-65.
4. Angold A, Costello EJ, Erkanli A, Worthman CM. Pubertal changes in hormone levels and depression in girls. Psychol Med 1999;29:1043-53.
5. Pine DS, Cohen E, Cohen P, Brook J. Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder? Am J Psychiatry 1999;156:133-5.
6. Pine DS, Cohen P, Gurley D, Brook J, Ma Y. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998;55:56-64.
7. Kann L, Kinchen SA, Williams BI, Ross JG, Lowry R, Grunbaum JA, et al. Youth Risk Behavior Surveillance - United States, 1999. State and local YRBSS Coordinators. J Sch Health 2000;70:271-85.
8. Brent DA. Assessment and treatment of the youthful suicidal patient. Ann N Y Acad Sci 2001;932:106-28.
9. National Institute of Mental Health. Blueprint for change: research on child and adolescent mental health. Bethesda, Md.: National Advisory Mental Health Council's Workgroup on Child and Adolescent Mental Health Intervention, Prevention, and Deployment, 2001. Accessed September 21, 2006, at: http://www.nimh.nih.gov/publicat/nimhblueprint.pdf.
10. National Institute of Mental Health. Depression in children and adolescents: a fact sheet for physicians. Bethesda, Md.: National Institute of Mental Health. Accessed September 21, 2006, at: http://www.mentalhealth-matters. com/articles/article.php?artID=320.
11. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002;297:400-3.
12. Warner V, Weissman MM, Mufson L, Wickramaratne PJ. Grandparents, parents, and grandchildren at high risk for depression: a three-generation study. J Am Acad Child Adolesc Psychiatry 1999;38:289-96.
13. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;45:515-9.
14. Pine DS, Cohen P, Brook J. Adolescent fears as predictors of depression. Biol Psychiatry 2001;50;721-4.
15. Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry 1999;40:57-87.
16. U.S. Preventive Services Task Force. Screening for depression: recommendations and rationale. Ann Intern Med 2002;136:760-4.
17. Kovacs M. The Children's Depression Inventory. North Tonawanda, N.Y.: Multi-Health Systems, 1992.
18. Hazell P. Depression in children and adolescents. Clin Evid 2004;12:427-42.
19. Timbremont B, Braet C, Dreessen L. Assessing depression in youth: relation between the Children's Depression Inventory and a structured interview. J Clin Child Adolesc Psychol 2004;33:149-57.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. rev. Washington, D.C.: American Psychiatric Association, 2000.
21. Birmaher B, Williamson DE, Dahl RE, Axelson DA, Kaufman J, Dorn LD, et al. Clinical presentation and course of depression in youth: does onset in childhood differ from onset in adolescence? J Am Acad Child Adolesc Psychiatry 2004;43:63-70.
22. Weller EB, Weller RA, Danielyan AK. Mood disorders in prepubertal children. In: Wiener JM, Dulcan MK, eds. Textbook of Child and Adolescent Psychiatry. 3rd ed. Washington, D.C.: American Psychiatric Publishing, 2004:411-35.
23. Weller EB, Weller RA, Danielyan AK. Mood disorders in adolescents. In: Wiener JM, Dulcan MK, eds. Textbook of Child and Adolescent Psychiatry. 3rd ed. Washington, D.C.: American Psychiatric Publishing, 2004:437-81.
24. Chambers WJ, Puig-Antich J, Tabrizi MA, Davies M. Psychotic symptoms in prepubertal major depressive disorder. Arch Gen Psychiatry 1982;39:921-7.
25. Riggs PD, Davies RD. A clinical approach to integrating treatment for adolescent depression and substance abuse. J Am Acad Child Adolesc Psychiatry 2002;41:1253-5.
26. Kovacs M, Akiskal HS, Gatsonis C, Parrone PL. Childhood-onset dysthymic disorder. Clinical features and prospective naturalistic outcome. Arch Gen Psychiatry 1994;51:365-74.
27. Williamson DE, Birmaher B, Brent DA, Balach L, Dahl RE, Ryan ND. Atypical symptoms of depression in a sample of depressed child and adolescent outpatients. J Am Acad Child Adolesc Psychiatry 2000;39:1253-9.
28. Akiskal HS. Developmental pathways to bipolarity: are juvenileonset depressions pre-bipolar? J Am Acad Child Adolesc Psychiatry 1995;34:754-63.
29. Birmaher B, Brent DA, Benson RS, for the American Academy of Child and Adolescent Psychiatry. Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 1998;37:1234-8.
30. Grunbaum JA, Kann L, Kinchen SA, Williams B, Ross JG, Lowry R, et al. Youth risk behavior surveillance - United States, 2001. MMWR Surveill Summ 2002;51:1-62.
31. Anderson RN. Deaths: leading causes for 2000. Natl Vital Stat Rep 2002;50:1-85.
32. Gould MS, Greenberg T, Velting DM, Shaffer D. Youth suicide risk and preventive interventions: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2003;42:386-405.
33. Johnson JG, Cohen P, Gould MS, Kasen S, Brown J, Brook JS. Childhood adversities, interpersonal difficulties, and risk for suicide attempts during late adolescence and early adulthood. Arch Gen Psychiatry 2002;59:741-9.
34. Gould MS, Fisher P, Parides M, Flory M, Shaffer D. Psychosocial risk factors of child and adolescent completed suicide. Arch Gen Psychiatry 1996;53:1155-62.
35. Agerbo E, Nordentoft M, Mortensen PB. Familial, psychiatric, and socioeconomic risk factors for suicide in young people: nested case-control study. BMJ 2002;325:74.
36. McGuffin P, Marusic A, Farmer A. What can psychiatric genetics offer suicidology? Crisis 2001;22:61-5.
37. Harrington R, Whittaker J, Shoebridge P. Psychological treatment of depression in children and adolescents. A review of treatment research. Br J Psychiatry 1998;173:291-8.
38. Reinecke MA, Ryan NE, DuBoise DL. Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry 1998;37:26-34.
39. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et al., for the Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 2004;292:807-20.
40. Hazell P, O'Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ 1995;310:897-901.
41. Maneeton N, Srisurapanont M. Tricyclic antidepressants for depressive disorders in children and adolescents: a meta-analysis of randomized-controlled trials. J Med Assoc Thai 2000;83:1367-74.
42. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-5.
43. Courtney DB. Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials. Can J Psychiatry 2004;49:557-63.
44. Medicines and Healthcare Products Regulatory Agency. Selective serotonin re-uptake inhibitors (SSRIs). London, U.K.: Commission on Human Medicines, 2006. Accessed September 21, 2006, at: http://www.mhra.gov.uk/home/idcplg?IdcService= SS_GET_PAGE&nodeId=242.
45. Hazell P, O'Connell D, Heathcote D, Henry D. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2002;(2):CD002317.
46. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002;41:1205-15.
47. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, et al., for the Sertraline Pediatric Depression Study Group. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 2003;290:1033-41.
48. Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72.
49. Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004;161:1079-83.
50. Mulrow CD, Williams JW Jr, Trivedi M, Chiquette E, Aguilar C, Cornell JE, et al. Treatment of depression - newer pharmacotherapies. Evid Rep Technol Assess (Summ) 1999;7:1-4.
51. Gunnell D, Ashby D. Antidepressants and suicide: what is the balance of benefit and harm. BMJ 2004;329:34-8.
52. Garland EJ. Facing the evidence: antidepressant treatment in children and adolescents. CMAJ 2004;170:489-91.
53. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials [Published correction appears in BMJ 2005;330:653]. BMJ 2005;330:396-402.
54. U.S. Food and Drug Administration (FDA). FDA issues public health advisory entitled: Reports of suicidality in pediatric patients being treated with antidepressant medications for major depressive disorder (MDD) [FDA Talk Paper]. Washington, D.C.: FDA, October 27, 2003. Accessed September 22, 2006, at: http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01256.html.
55. "Black Box" warning for antidepressants [transcript]. Washington, D.C.: U.S. Food and Drug Administration, December 2004. Accessed September 21, 2006, at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/ printer.cfm?id=275.
56. Duffy A. Toward effective early intervention and prevention strategies for major affective disorders: a review of antecedents and risk factors. Can J Psychiatry 2000;45:340-8.